BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36818425)

  • 1. PANoptosis is a prominent feature of desmoplakin cardiomyopathy.
    Olcum M; Rouhi L; Fan S; Gonzales MM; Jeong HH; Zhao Z; Gurha P; Marian AJ
    J Cardiovasc Aging; 2023 Feb; 3(1):. PubMed ID: 36818425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic inactivation of β-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy.
    Olcum M; Fan S; Rouhi L; Cheedipudi S; Cathcart B; Jeong HH; Zhao Z; Gurha P; Marian AJ
    Cardiovasc Res; 2023 Dec; 119(17):2712-2728. PubMed ID: 37625794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy.
    Yuan P; Cheedipudi SM; Rouhi L; Fan S; Simon L; Zhao Z; Hong K; Gurha P; Marian AJ
    Circulation; 2021 Jun; 143(22):2169-2187. PubMed ID: 33726497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Fan S; Rouhi L; Marian AJ
    J Cardiovasc Aging; 2021; 1(3):. PubMed ID: 34447973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Hu J; Fan S; Yuan P; Karmouch J; Czernuszewicz G; Robertson MJ; Coarfa C; Hong K; Yao Y; Campbell H; Wehrens X; Gurha P; Marian AJ
    Cardiovasc Res; 2020 May; 116(6):1199-1213. PubMed ID: 31350552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
    Smith ED; Lakdawala NK; Papoutsidakis N; Aubert G; Mazzanti A; McCanta AC; Agarwal PP; Arscott P; Dellefave-Castillo LM; Vorovich EE; Nutakki K; Wilsbacher LD; Priori SG; Jacoby DL; McNally EM; Helms AS
    Circulation; 2020 Jun; 141(23):1872-1884. PubMed ID: 32372669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
    Rouhi L; Cheedipudi SM; Chen SN; Fan S; Lombardi R; Chen X; Coarfa C; Robertson MJ; Gurha P; Marian AJ
    Cardiovasc Res; 2021 Sep; 117(11):2377-2394. PubMed ID: 33070193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity.
    Brandão M; Bariani R; Rigato I; Bauce B
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Yang Z; Bowles NE; Scherer SE; Taylor MD; Kearney DL; Ge S; Nadvoretskiy VV; DeFreitas G; Carabello B; Brandon LI; Godsel LM; Green KJ; Saffitz JE; Li H; Danieli GA; Calkins H; Marcus F; Towbin JA
    Circ Res; 2006 Sep; 99(6):646-55. PubMed ID: 16917092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tamoxifen inducible MerCreMer on gene expression in cardiac myocytes in mice.
    Rouhi L; Fan S; Cheedipudi SM; Olcum M; Jeong HH; Zhao Z; Gurha P; Marian AJ
    J Cardiovasc Aging; 2022; 2():. PubMed ID: 35079750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report.
    Lemus Barrios GA; Lopez-Lopez JP; Barbosa-Balaguera S; Correa AM
    ESC Heart Fail; 2023 Oct; 10(5):3190-3194. PubMed ID: 37632291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case series of desmoplakin cardiomyopathy: a mimic of viral myocarditis.
    Rezaei Bookani K; Minga I; Wodskow J; Harris J; Gordon R; Sarswat N; Pursnani A
    Eur Heart J Case Rep; 2022 Aug; 6(8):ytac341. PubMed ID: 36043215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates.
    Costa S; Cerrone M; Saguner AM; Brunckhorst C; Delmar M; Duru F
    Trends Cardiovasc Med; 2021 Oct; 31(7):395-402. PubMed ID: 32738304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model.
    Lyon RC; Mezzano V; Wright AT; Pfeiffer E; Chuang J; Banares K; Castaneda A; Ouyang K; Cui L; Contu R; Gu Y; Evans SM; Omens JH; Peterson KL; McCulloch AD; Sheikh F
    Hum Mol Genet; 2014 Mar; 23(5):1134-50. PubMed ID: 24108106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
    Rouhi L; Fan S; Cheedipudi SM; Braza-Boïls A; Molina MS; Yao Y; Robertson MJ; Coarfa C; Gimeno JR; Molina P; Gurha P; Zorio E; Marian AJ
    Cardiovasc Res; 2022 May; 118(6):1466-1478. PubMed ID: 34132777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling.
    Martherus R; Jain R; Takagi K; Mendsaikhan U; Turdi S; Osinska H; James JF; Kramer K; Purevjav E; Towbin JA
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H174-87. PubMed ID: 26545710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoplakin and clinical manifestations of desmoplakin cardiomyopathy.
    Yuan ZY; Cheng LT; Wang ZF; Wu YQ
    Chin Med J (Engl); 2021 Aug; 134(15):1771-1779. PubMed ID: 34343150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized
    Stevens TL; Manring HR; Wallace MJ; Argall A; Dew T; Papaioannou P; Antwi-Boasiako S; Xu X; Campbell SG; Akar FG; Borzok MA; Hund TJ; Mohler PJ; Koenig SN; El Refaey M
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the
    Rouhi L; Auguste G; Zhou Q; Lombardi R; Olcum M; Pourebrahim K; Cheedipudi SM; Asghar S; Hong K; Robertson MJ; Coarfa C; Gurha P; Marian AJ
    J Cardiovasc Aging; 2022 Jul; 2(3):. PubMed ID: 35891706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.